{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:32:48Z","timestamp":1792877568648,"version":"4.5.0"},"reference-count":215,"publisher":"Bentham Science Publishers Ltd.","issue":"10","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973918"],"award-info":[{"award-number":["81973918"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274616"],"award-info":[{"award-number":["82274616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key laboratory project of colleges and universities in Guangdong Province","award":["2019KSYS005"],"award-info":[{"award-number":["2019KSYS005"]}]},{"name":"Guangdong province science and technology plan international cooperation project","award":["2020A0505100052"],"award-info":[{"award-number":["2020A0505100052"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Neurodegenerative diseases encompass a collection of neurological disorders originating from the progressive degeneration of neurons, resulting in the dysfunction of neurons. Unfortunately, effective therapeutic interventions for these diseases are presently lacking. Copper (Cu), a crucial trace element within the human body, assumes a pivotal role in various biological metabolic processes, including energy metabolism, antioxidant defense, and neurotransmission. These processes are vital for the sustenance, growth, and development of organisms. Mounting evidence suggests that disrupted copper homeostasis contributes to numerous age-related neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), Wilson's disease (WD), Menkes disease (MD), prion diseases, and multiple sclerosis (MS). This comprehensive review investigates the connection between the imbalance of copper homeostasis and neurodegenerative diseases, summarizing pertinent drugs and therapies that ameliorate neuropathological changes, motor deficits, and cognitive impairments in these conditions through the modulation of copper metabolism. These interventions include Metal-Protein Attenuating Compounds (MPACs), copper chelators, copper supplements, and zinc salts. Moreover, this review highlights the potential of active compounds derived from natural plant medicines to enhance neurodegenerative disease outcomes by regulating copper homeostasis. Among these compounds, polyphenols are particularly abundant. Consequently, this review holds significant implications for the future development of innovative drugs targeting the treatment of neurodegenerative diseases.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1570159x22666231103085859","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T10:37:22Z","timestamp":1701427042000},"page":"1650-1671","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds"],"prefix":"10.2174","volume":"22","author":[{"given":"Guangcheng","family":"Zhong","sequence":"first","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[{"name":"The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyuan","family":"Xie","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqing","family":"Wu","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Chen","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Cao","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyao","family":"Li","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinman","family":"Liu","sequence":"additional","affiliation":[{"name":"Affiliated Jiangmen TCM Hospital of Ji'nan University, Jiangmen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","volume":"13","author":"Hetz C.","year":"2017","unstructured":"Hetz C.; Saxena S.; ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol 2017,13(8),477-491","journal-title":"Nat Rev Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"Barnham K.J.","year":"2004","unstructured":"Barnham K.J.; Masters C.L.; Bush A.I.; Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004,3(3),205-214","journal-title":"Nat Rev Drug Discov"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"Nixon R.A.","year":"2013","unstructured":"Nixon R.A.; The role of autophagy in neurodegenerative disease. Nat Med 2013,19(8),983-997","journal-title":"Nat Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"Ross C.A.","year":"2004","unstructured":"Ross C.A.; Poirier M.A.; Protein aggregation and neurodegenerative disease. Nat Med 2004,10(S7)(Suppl.),S10-S17","journal-title":"Nat Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","volume":"121","author":"Nguyen P.H.","year":"2021","unstructured":"Nguyen P.H.; Ramamoorthy A.; Sahoo B.R.; Zheng J.; Faller P.; Straub J.E.; Dominguez L.; Shea J.E.; Dokholyan N.V.; De Simone A.; Ma B.; Nussinov R.; Najafi S.; Ngo S.T.; Loquet A.; Chiricotto M.; Ganguly P.; McCarty J.; Li M.S.; Hall C.; Wang Y.; Miller Y.; Melchionna S.; Habenstein B.; Timr S.; Chen J.; Hnath B.; Strodel B.; Kayed R.; Lesn&#xE9; S.; Wei G.; Sterpone F.; Doig A.J.; Derreumaux P.; Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, Type II diabetes, and amyotrophic lateral sclerosis. Chem Rev 2021,121(4),2545-2647","journal-title":"Chem Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/645379","volume":"2013","author":"Arnal N.","year":"2013","unstructured":"Arnal N.; Castillo O.; de Alaniz M.J.T.; Marra C.A.; Effects of copper and\/or cholesterol overload on mitochondrial function in a rat model of incipient neurodegeneration. Int J Alzheimers Dis 2013,2013,1-14","journal-title":"Int J Alzheimers Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(03)00353-3","volume":"2","author":"Ke Y.","year":"2003","unstructured":"Ke Y.; Qian Z.M.; Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2003,2(4),246-253","journal-title":"Lancet Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","volume":"472","author":"Chen J.","year":"2020","unstructured":"Chen J.; Jiang Y.; Shi H.; Peng Y.; Fan X.; Li C.; The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch 2020,472(10),1415-1429","journal-title":"Pflugers Arch"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41430-017-0002-0","volume":"72","author":"Russell K.","year":"2018","unstructured":"Russell K.; Gillanders L.K.; Orr D.W.; Plank L.D.; Dietary copper restriction in Wilson\u2019s disease. Eur J Clin Nutr 2018,72(3),326-331","journal-title":"Eur J Clin Nutr"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"113759","DOI":"10.1016\/j.fct.2023.113759","volume":"176","author":"Kolbaum A.E.","year":"2023","unstructured":"Kolbaum A.E.; Sarvan I.; Bakhiya N.; Spolders M.; Pieper R.; Schubert J.; Jung C.; Hackethal C.; Sieke C.; Gr&#xFC;newald K.H.; Lindtner O.; Long-term dietary exposure to copper in the population in Germany \u2013 Results from the BfR MEAL study. Food Chem Toxicol 2023,176,113759","journal-title":"Food Chem Toxicol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1021\/jf034860l","volume":"52","year":"2004","unstructured":"Toku&#x15F;o&#x1E7;lu, &#xD6;.; Aycan, &#x15E;.; Akalin, S.; Ko&#xE7;ak, S.; Ersoy, N. Simultaneous differential pulse polarographic determination of cadmium, lead, and copper in milk and dairy products. J Agric Food Chem 2004,52(7),1795-1799","journal-title":"J Agric Food Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.10.006","volume":"133","author":"Zheng W.","year":"2012","unstructured":"Zheng W.; Monnot A.D.; Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases. Pharmacol Ther 2012,133(2),177-188","journal-title":"Pharmacol Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.3390\/nu7125513","volume":"7","author":"Brewer G.","year":"2015","unstructured":"Brewer G.; Copper-2 ingestion, plus increased meat eating leading to increased copper absorption, are major factors behind the current epidemic of Alzheimer\u2019s disease. Nutrients 2015,7(12),10053-10064","journal-title":"Nutrients"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"711227","DOI":"10.3389\/fmolb.2021.711227","volume":"8","author":"Ruiz L.M.","year":"2021","unstructured":"Ruiz L.M.; Libedinsky A.; Elorza A.A.; Role of copper on mitochondrial function and metabolism. Front Mol Biosci 2021,8,711227","journal-title":"Front Mol Biosci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pneurobio.2014.01.002","volume":"116","author":"Scheiber I.F.","year":"2014","unstructured":"Scheiber I.F.; Mercer J.F.B.; Dringen R.; Metabolism and functions of copper in brain. Prog Neurobiol 2014,116,33-57","journal-title":"Prog Neurobiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.mam.2005.07.010","volume":"26","author":"Arredondo M.","year":"2005","unstructured":"Arredondo M.; N&#xFA;&#xF1;ez M.T.; Iron and copper metabolism. Mol Aspects Med 2005,26(4-5),313-327","journal-title":"Mol Aspects Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"9259","DOI":"10.3390\/ijms21239259","volume":"21","author":"Gromadzka G.","year":"2020","unstructured":"Gromadzka G.; Tarnacka B.; Flaga A.; Adamczyk A.; Copper dyshomeostasis in neurodegenerative diseases-therapeutic implications. Int J Mol Sci 2020,21(23),9259","journal-title":"Int J Mol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2010.180","volume":"7","author":"Kaler S.G.","year":"2011","unstructured":"Kaler S.G.; ATP7A-related copper transport diseases\u2014emerging concepts and future trends. Nat Rev Neurol 2011,7(1),15-29","journal-title":"Nat Rev Neurol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"103228","DOI":"10.1016\/j.msard.2021.103228","volume":"56","author":"Rasoul A.A.","year":"2021","unstructured":"Rasoul A.A.; Khudhur Z.O.; Hamad M.S.; Ismaeal Y.S.; Smail S.W.; Rasul M.F.; Mohammad K.A.; Bapir A.A.; Omar S.A.; Qadir M.K.; Rajab M.F.; Salihi A.; Kaleem M.; Rizwan M.A.; Qureshi A.S.; Iqbal Z.M.; Qudratullah. The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population. Mult Scler Relat Disord 2021,56,103228","journal-title":"Mult Scler Relat Disord"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"Tsvetkov P.","year":"2022","unstructured":"Tsvetkov P.; Coy S.; Petrova B.; Dreishpoon M.; Verma A.; Abdusamad M.; Rossen J.; Joesch-Cohen L.; Humeidi R.; Spangler R.D.; Eaton J.K.; Frenkel E.; Kocak M.; Corsello S.M.; Lutsenko S.; Kanarek N.; Santagata S.; Golub T.R.; Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 2022,375(6586),1254-1261","journal-title":"Science"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"13850","DOI":"10.3390\/ijms232213850","volume":"23","author":"An Y.","year":"2022","unstructured":"An Y.; Li S.; Huang X.; Chen X.; Shan H.; Zhang M.; The role of copper homeostasis in brain disease. Int J Mol Sci 2022,23(22),13850","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.3233\/JAD-170374","volume":"60","author":"Law B.Y.K.","year":"2017","unstructured":"Law B.Y.K.; Wu A.G.; Wang M.J.; Zhu Y.Z.; Chinese medicine: a hope for neurodegenerative diseases? J Alzheimers Dis 2017,60(s1),S151-S160","journal-title":"J Alzheimers Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1142\/S0192415X20500251","volume":"48","author":"Pei H.","year":"2020","unstructured":"Pei H.; Ma L.; Cao Y.; Wang F.; Li Z.; Liu N.; Liu M.; Wei Y.; Li H.; Traditional Chinese medicine for Alzheimer\u2019s disease and other cognitive impairment: A review. Am J Chin Med 2020,48(3),487-511","journal-title":"Am J Chin Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.bbadis.2018.03.007","volume":"1864","author":"De Riccardis L.","year":"2018","unstructured":"De Riccardis L.; Buccolieri A.; Muci M.; Pitotti E.; De Robertis F.; Trianni G.; Manno D.; Maffia M.; Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects. Biochim Biophys Acta Mol Basis Dis 2018,1864(5),1828-1838","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41419-018-0379-2","volume":"9","author":"Sheykhansari S.","year":"2018","unstructured":"Sheykhansari S.; Kozielski K.; Bill J.; Sitti M.; Gemmati D.; Zamboni P.; Singh A.V.; Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: A review. Cell Death Dis 2018,9(3),348","journal-title":"Cell Death Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fphys.2013.00111","volume":"4","author":"Hung Y.H.","year":"2013","unstructured":"Hung Y.H.; Bush A.I.; La Fontaine S.; Links between copper and cholesterol in Alzheimer\u2019s disease. Front Physiol 2013,4,111","journal-title":"Front Physiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1471-4159.2009.06310.x","volume":"111","author":"Tokuda E.","year":"2009","unstructured":"Tokuda E.; Okawa E.; Ono S.; Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper\/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis. J Neurochem 2009,111(1),181-191","journal-title":"J Neurochem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/nu14030700","volume":"14","author":"Liu Y.","year":"2022","unstructured":"Liu Y.; Miao J.; An emerging role of defective copper metabolism in heart disease. Nutrients 2022,14(3),700","journal-title":"Nutrients"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/erm.2017.9","volume":"19","author":"Gil-Bea F.J.","year":"2017","unstructured":"Gil-Bea F.J.; Aldanondo G.; Lasa-Fern&#xE1;ndez H.; L&#xF3;pez de Munain A.; Vallejo-Illarramendi A.; Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis. Expert Rev Mol Med 2017,19,e7","journal-title":"Expert Rev Mol Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1039\/C2MT20151H","volume":"5","author":"Davies K.M.","year":"2013","unstructured":"Davies K.M.; Hare D.J.; Cottam V.; Chen N.; Hilgers L.; Halliday G.; Mercer J.F.B.; Double K.L.; Localization of copper and copper transporters in the human brain. Metallomics 2013,5(1),43-51","journal-title":"Metallomics"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fphar.2012.00169","volume":"3","author":"Skj&#xF8;rringe T.","year":"2012","unstructured":"Skj&#xF8;rringe T.; M&#xF8;ller L.B.; Moos T.; Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders. Front Pharmacol 2012,3,169","journal-title":"Front Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"Sweeney M.D.","year":"2018","unstructured":"Sweeney M.D.; Sagare A.P.; Zlokovic B.V.; Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 2018,14(3),133-150","journal-title":"Nat Rev Neurol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jcpa.2013.09.002","volume":"150","author":"Haywood S.","year":"2014","unstructured":"Haywood S.; Vaillant C.; Overexpression of copper transporter CTR1 in the brain barrier of North Ronaldsay sheep: Implications for the study of neurodegenerative disease. J Comp Pathol 2014,150(2-3),216-224","journal-title":"J Comp Pathol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/toxsci\/kfy025","volume":"163","author":"Hsu H.W.","year":"2018","unstructured":"Hsu H.W.; Bondy S.C.; Kitazawa M.; Environmental and dietary exposure to copper and its cellular mechanisms linking to Alzheimer\u2019s disease. Toxicol Sci 2018,163(2),338-345","journal-title":"Toxicol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/10408444.2020.1838441","volume":"50","author":"Ijomone O.M.","year":"2020","unstructured":"Ijomone O.M.; Ifenatuoha C.W.; Aluko O.M.; Ijomone O.K.; Aschner M.; The aging brain: impact of heavy metal neurotoxicity. Crit Rev Toxicol 2020,50(9),801-814","journal-title":"Crit Rev Toxicol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev.neuro.30.051606.094232","volume":"30","author":"Madsen E.","year":"2007","unstructured":"Madsen E.; Gitlin J.D.; Copper and iron disorders of the brain. Annu Rev Neurosci 2007,30(1),317-337","journal-title":"Annu Rev Neurosci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/JMDH.S93454","volume":"9","author":"Prasad A.N.","year":"2016","unstructured":"Prasad A.N.; Ojha R.; Menkes disease: What a multidisciplinary approach can do. J Multidiscip Healthc 2016,9,371-385","journal-title":"J Multidiscip Healthc"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"Goedert M.","year":"2015","unstructured":"Goedert M.; Alzheimer\u2019s and Parkinson\u2019s diseases: The prion concept in relation to assembled A&#x3B2; tau, and &#x3B1;-synuclein. Science 2015,349(6248),1255555","journal-title":"Science"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/ADR-200171","volume":"4","author":"Sinyor B.","year":"2020","unstructured":"Sinyor B.; Mineo J.; Ochner C.; Alzheimer\u2019s disease, inflammation, and the role of antioxidants. J Alzheimers Dis Rep 2020,4(1),175-183","journal-title":"J Alzheimers Dis Rep"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1212\/01.WNL.0000154531.79362.23","volume":"64","author":"Squitti R.","year":"2005","unstructured":"Squitti R.; Pasqualetti P.; Dal Forno G.; Moffa F.; Cassetta E.; Lupoi D.; Vernieri F.; Rossi L.; Baldassini M.; Rossini P.M.; Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 2005,64(6),1040-1046","journal-title":"Neurology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","volume":"48","author":"Robert A.","year":"2015","unstructured":"Robert A.; Liu Y.; Nguyen M.; Meunier B.; Regulation of copper and iron homeostasis by metal chelators: A possible chemotherapy for Alzheimer\u2019s disease. Acc Chem Res 2015,48(5),1332-1339","journal-title":"Acc Chem Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","volume":"158","author":"Lovell M.A.","year":"1998","unstructured":"Lovell M.A.; Robertson J.D.; Teesdale W.J.; Campbell J.L.; Markesbery W.R.; Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci 1998,158(1),47-52","journal-title":"J Neurol Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.3390\/ijms21207660","volume":"21","author":"Ejaz H.W.","year":"2020","unstructured":"Ejaz H.W.; Wang W.; Lang M.; Copper toxicity links to pathogenesis of Alzheimer\u2019s disease and therapeutics approaches. Int J Mol Sci 2020,21(20),7660","journal-title":"Int J Mol Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","volume":"143","author":"Deibel M.A.","year":"1996","unstructured":"Deibel M.A.; Ehmann W.D.; Markesbery W.R.; Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer\u2019s disease: Possible relation to oxidative stress. J Neurol Sci 1996,143(1-2),137-142","journal-title":"J Neurol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cbi.2010.04.010","volume":"186","author":"Rivera-Manc&#xED;a S.","year":"2010","unstructured":"Rivera-Manc&#xED;a S.; P&#xE9;rez-Neri I.; R&#xED;os C.; Trist&#xE1;n-L&#xF3;pez L.; Rivera-Espinosa L.; Montes S.; The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact 2010,186(2),184-199","journal-title":"Chem Biol Interact"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0006-8993(96)00782-2","volume":"738","author":"Loeffler D.A.","year":"1996","unstructured":"Loeffler D.A.; LeWitt P.A.; Juneau P.L.; Sima A.A.F.; Nguyen H.U.; DeMaggio A.J.; Brickman C.M.; Brewer G.J.; Dick R.D.; Troyer M.D.; Kanaley L.; Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 1996,738(2),265-274","journal-title":"Brain Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/145345","volume":"2013","author":"Choo X.Y.","year":"2013","unstructured":"Choo X.Y.; Alukaidey L.; White A.R.; Grubman A.; Neuroinflammation and copper in Alzheimer\u2019s disease. Int J Alzheimers Dis 2013,2013,1-12","journal-title":"Int J Alzheimers Dis"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fnagi.2017.00446","volume":"9","author":"Bagheri S.","year":"2018","unstructured":"Bagheri S.; Squitti R.; Haertl&#xE9; T.; Siotto M.; Saboury A.A.; Role of Copper in the onset of Alzheimer\u2019s disease compared to other metals. Front Aging Neurosci 2018,9,446","journal-title":"Front Aging Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"572308","DOI":"10.3389\/fnmol.2020.572308","volume":"13","year":"2020","unstructured":"Zub&#x10D;i\u0107 K.; Hof, P.R.; \u0160imi\u0107 G.; Jazvin\u0161\u0107ak Jembrek, M. The role of copper in tau-related pathology in Alzheimer\u2019s disease. Front Mol Neurosci 2020,13,572308","journal-title":"Front Mol Neurosci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2047-9158-3-24","volume":"3","author":"Voss K.","year":"2014","unstructured":"Voss K.; Harris C.; Ralle M.; Duffy M.; Murchison C.; Quinn J.F.; Modulation of tau phosphorylation by environmental copper. Transl Neurodegener 2014,3(1),24","journal-title":"Transl Neurodegener"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"14771","DOI":"10.1073\/pnas.1302212110","volume":"110","author":"Singh I.","year":"2013","unstructured":"Singh I.; Sagare A.P.; Coma M.; Perlmutter D.; Gelein R.; Bell R.D.; Deane R.J.; Zhong E.; Parisi M.; Ciszewski J.; Kasper R.T.; Deane R.; Low levels of copper disrupt brain amyloid-&#x3B2; homeostasis by altering its production and clearance. Proc Natl Acad Sci USA 2013,110(36),14771-14776","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"Busche M.A.","year":"2020","unstructured":"Busche M.A.; Hyman B.T.; Synergy between amyloid-&#x3B2; and tau in Alzheimer\u2019s disease. Nat Neurosci 2020,23(10),1183-1193","journal-title":"Nat Neurosci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"9461","DOI":"10.3390\/ijms22179461","volume":"22","author":"Aaseth J.","year":"2021","unstructured":"Aaseth J.; Skalny A.V.; Roos P.M.; Alexander J.; Aschner M.; Tinkov A.A.; Copper, iron, selenium and lipo-glycemic dysmetabolism in Alzheimer\u2019s disease. Int J Mol Sci 2021,22(17),9461","journal-title":"Int J Mol Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuro.2013.12.001","volume":"40","author":"Pal A.","year":"2014","unstructured":"Pal A.; Copper toxicity induced hepatocerebral and neurodegenerative diseases: An urgent need for prognostic biomarkers. Neurotoxicology 2014,40,97-101","journal-title":"Neurotoxicology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10534-013-9702-7","volume":"27","author":"Pal A.","year":"2014","unstructured":"Pal A.; Kumar A.; Prasad R.; Predictive association of copper metabolism proteins with Alzheimer\u2019s disease and Parkinson\u2019s disease: a preliminary perspective. Biometals 2014,27(1),25-31","journal-title":"Biometals"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"Bloem B.R.","year":"2021","unstructured":"Bloem B.R.; Okun M.S.; Klein C.; Parkinson\u2019s disease. Lancet 2021,397(10291),2284-2303","journal-title":"Lancet"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10534-018-0131-5","volume":"31","author":"Aaseth J.","year":"2018","unstructured":"Aaseth J.; Dusek P.; Roos P.M.; Prevention of progression in Parkinson\u2019s disease. Biometals 2018,31(5),737-747","journal-title":"Biometals"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"Tolosa E.","year":"2021","unstructured":"Tolosa E.; Garrido A.; Scholz S.W.; Poewe W.; Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 2021,20(5),385-397","journal-title":"Lancet Neurol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/147251","volume":"2014","author":"Montes S.","year":"2014","unstructured":"Montes S.; Rivera-Mancia S.; Diaz-Ruiz A.; Tristan-Lopez L.; Rios C.; Copper and copper proteins in Parkinson\u2019s disease. Oxid Med Cell Longev 2014,2014,1-15","journal-title":"Oxid Med Cell Longev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","volume":"144","author":"Wang Q.","year":"2021","unstructured":"Wang Q.; Luo Y.; Ray Chaudhuri K.; Reynolds R.; Tan E.K.; Pettersson S.; The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options. Brain 2021,144(9),2571-2593","journal-title":"Brain"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12291-016-0614-5","volume":"32","author":"Gangania M.K.","year":"2017","unstructured":"Gangania M.K.; Batra J.; Kushwaha S.; Agarwal R.; Role of iron and copper in the pathogenesis of Parkinson\u2019s disease. Indian J Clin Biochem 2017,32(3),353-356","journal-title":"Indian J Clin Biochem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"135873","DOI":"10.1016\/j.neulet.2021.135873","volume":"753","author":"Raj K.","year":"2021","unstructured":"Raj K.; Kaur P.; Gupta G.D.; Singh S.; Metals associated neurodegeneration in Parkinson\u2019s disease: Insight to physiological, pathological mechanisms and management. Neurosci Lett 2021,753,135873","journal-title":"Neurosci Lett"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JHD-120029","volume":"1","author":"Cherny R.A.","year":"2012","unstructured":"Cherny R.A.; Ayton S.; Finkelstein D.I.; Bush A.I.; McColl G.; Massa S.M.; PBT2 reduces toxicity in a c. elegans model of polyQ aggregation and extends lifespan, reduces striatal atrophy and improves motor performance in the R6\/2 mouse model of Huntington\u2019s disease. J Huntingtons Dis 2012,1(2),211-219","journal-title":"J Huntingtons Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1042\/BST0380552","volume":"38","author":"Hands S.L.","year":"2010","unstructured":"Hands S.L.; Mason R.; Sajjad M.U.; Giorgini F.; Wyttenbach A.; Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington\u2019s disease. Biochem Soc Trans 2010,38(2),552-558","journal-title":"Biochem Soc Trans"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"Dexter D.T.","year":"1991","unstructured":"Dexter D.T.; Carayon A.; Javoy-Agid F.; Agid Y.; Wells F.R.; Daniel S.E.; Lees A.J.; Jenner P.; Marsden C.D.; Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991,114(4),1953-1975","journal-title":"Brain"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"101152","DOI":"10.1016\/j.arr.2020.101152","volume":"63","author":"Scholefield M.","year":"2020","unstructured":"Scholefield M.; Unwin R.D.; Cooper G.J.S.; Shared perturbations in the metallome and metabolome of Alzheimer\u2019s, Parkinson\u2019s, Huntington\u2019s, and dementia with Lewy bodies: A systematic review. Ageing Res Rev 2020,63,101152","journal-title":"Ageing Res Rev"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1111\/bph.12513","volume":"171","author":"Grubman A.","year":"2014","unstructured":"Grubman A.; White A.R.; Liddell J.R.; Mitochondrial metals as a potential therapeutic target in neurodegeneration. Br J Pharmacol 2014,171(8),2159-2173","journal-title":"Br J Pharmacol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e21810","DOI":"10.1096\/fj.202100273RR","volume":"35","author":"Maung M.T.","year":"2021","unstructured":"Maung M.T.; Carlson A.; Olea-Flores M.; Elkhadragy L.; Schachtschneider K.M.; Navarro-Tito N.; Padilla-Benavides T.; The molecular and cellular basis of copper dysregulation and its relationship with human pathologies. FASEB J 2021,35(9),e21810","journal-title":"FASEB J"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1371\/journal.pone.0000334","volume":"2","author":"Fox J.H.","year":"2007","unstructured":"Fox J.H.; Kama J.A.; Lieberman G.; Chopra R.; Dorsey K.; Chopra V.; Volitakis I.; Cherny R.A.; Bush A.I.; Hersch S.; Mechanisms of copper ion mediated Huntington\u2019s disease progression. PLoS One 2007,2(3),e334","journal-title":"PLoS One"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/brain\/awaa309","volume":"143","author":"Clarke B.E.","year":"2020","unstructured":"Clarke B.E.; Patani R.; The microglial component of amyotrophic lateral sclerosis. Brain 2020,143(12),3526-3539","journal-title":"Brain"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.tins.2021.04.008","volume":"44","author":"Van Harten A.C.M.","year":"2021","unstructured":"Van Harten A.C.M.; Phatnani H.; Przedborski S.; Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci 2021,44(8),658-668","journal-title":"Trends Neurosci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1385\/BTER:96:1-3:39","volume":"96","author":"Gellein K.","year":"2003","unstructured":"Gellein K.; Garruto R.M.; Syversen T.; Sj&#xF8;bakk T.E.; Flaten T.P.; Concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam determined by High-resolution ICP-MS. Biol Trace Elem Res 2003,96(1-3),39-60","journal-title":"Biol Trace Elem Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0022-510X(96)05334-8","volume":"147","author":"Kapaki E.","year":"1997","unstructured":"Kapaki E.; Zournas C.; Kanias G.; Zambelis T.; Kakami A.; Papageorgiou C.; Essential trace element alterations in amyotrophic lateral sclerosis. J Neurol Sci 1997,147(2),171-175","journal-title":"J Neurol Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5678698","volume":"2018","author":"Barros A.N.A.B.","year":"2018","unstructured":"Barros A.N.A.B.; Dourado M.E.T.; Pedrosa L.F.C.; Leite-Lais L.; Association of copper status with lipid profile and functional status in patients with amyotrophic lateral sclerosis. J Nutr Metab 2018,2018,1-7","journal-title":"J Nutr Metab"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"e202000069","DOI":"10.1002\/jbio.202000069","volume":"13","author":"Kreuzer M.","year":"2020","unstructured":"Kreuzer M.; Stamenkovi\u0107 S.; Chen, S.; Andjus, P.; Du&#x10D;i\u0107 T. Lipids status and copper in a single astrocyte of the rat model for amyotrophic lateral sclerosis: Correlative synchrotron\u2010based X\u2010ray and infrared imaging. J Biophotonics 2020,13(10),e202000069","journal-title":"J Biophotonics"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14728222.2020.1738390","volume":"24","author":"Abati E.","year":"2020","unstructured":"Abati E.; Bresolin N.; Comi G.; Corti S.; Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS). Expert Opin Ther Targets 2020,24(4),295-310","journal-title":"Expert Opin Ther Targets"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00109-015-1273-3","volume":"93","author":"Hilton J.B.","year":"2015","unstructured":"Hilton J.B.; White A.R.; Crouch P.J.; Metal-deficient SOD1 in amyotrophic lateral sclerosis. J Mol Med (Berl) 2015,93(5),481-487","journal-title":"J Mol Med (Berl)"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.mcn.2018.03.001","volume":"88","author":"Enge T.G.","year":"2018","unstructured":"Enge T.G.; Ecroyd H.; Jolley D.F.; Yerbury J.J.; Kalmar B.; Dosseto A.; Assessment of metal concentrations in the SOD1G93A mouse model of amyotrophic lateral sclerosis and its potential role in muscular denervation, with particular focus on muscle tissue. Mol Cell Neurosci 2018,88,319-329","journal-title":"Mol Cell Neurosci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.bbadis.2018.03.015","volume":"1864","author":"Tokuda E.","year":"2018","unstructured":"Tokuda E.; Nomura T.; Ohara S.; Watanabe S.; Yamanaka K.; Morisaki Y.; Misawa H.; Furukawa Y.; A copper-deficient form of mutant Cu\/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis. Biochim Biophys Acta Mol Basis Dis 2018,1864(6),2119-2130","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/molecules22091429","volume":"22","author":"Sirangelo I.","year":"2017","unstructured":"Sirangelo I.; Iannuzzi C.; The role of metal binding in the amyotrophic lateral sclerosis-related aggregation of copper-zinc superoxide dismutase. Molecules 2017,22(9),1429","journal-title":"Molecules"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.isci.2018.07.023","volume":"6","author":"Sauz&#xE9;at L.","year":"2018","unstructured":"Sauz&#xE9;at L.; Bernard E.; Perret-Liaudet A.; Quadrio I.; Vighetto A.; Krolak-Salmon P.; Broussolle E.; Leblanc P.; Balter V.; Isotopic evidence for disrupted copper metabolism in amyotrophic lateral sclerosis. iScience 2018,6,264-271","journal-title":"iScience"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.3390\/ijms22157820","volume":"22","author":"Tarnacka B.","year":"2021","unstructured":"Tarnacka B.; Jopowicz A.; Ma&#x15B;li\u0144ska, M. Copper, iron, and manganese toxicity in neuropsychiatric conditions. Int J Mol Sci 2021,22(15),7820","journal-title":"Int J Mol Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ana.410060105","volume":"6","author":"Kurlander H.M.","year":"1979","unstructured":"Kurlander H.M.; Patten B.M.; Metals in spinal cord tissue of patients dying of motor neuron disease. Ann Neurol 1979,6(1),21-24","journal-title":"Ann Neurol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/brain\/awac077","volume":"145","author":"Katzeff J.S.","year":"2022","unstructured":"Katzeff J.S.; Bright F.; Phan K.; Kril J.J.; Ittner L.M.; Kassiou M.; Hodges J.R.; Piguet O.; Kiernan M.C.; Halliday G.M.; Kim W.S.; Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 2022,145(5),1598-1609","journal-title":"Brain"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.expneurol.2008.05.011","volume":"213","author":"Tokuda E.","year":"2008","unstructured":"Tokuda E.; Ono S.; Ishige K.; Watanabe S.; Okawa E.; Ito Y.; Suzuki T.; Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis. Exp Neurol 2008,213(1),122-128","journal-title":"Exp Neurol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","volume":"14","author":"Bandmann O.","year":"2015","unstructured":"Bandmann O.; Weiss K.H.; Kaler S.G.; Wilson\u2019s disease and other neurological copper disorders. Lancet Neurol 2015,14(1),103-113","journal-title":"Lancet Neurol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2010.07.008","volume":"53","author":"Lalioti V.","year":"2010","unstructured":"Lalioti V.; Sandoval I.; Cassio D.; Duclos-Vall&#xE9;e J.C.; Molecular pathology of Wilson\u2019s disease: A brief. J Hepatol 2010,53(6),1151-1153","journal-title":"J Hepatol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"e0190887","DOI":"10.1371\/journal.pone.0190887","volume":"13","author":"Xu R.","year":"2018","unstructured":"Xu R.; Jiang Y.; Zhang Y.; Yang X.; The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson\u2019s disease: A large hospital-based study. PLoS One 2018,13(1),e0190887","journal-title":"PLoS One"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1058642","DOI":"10.3389\/fneur.2022.1058642","volume":"13","author":"Yang Y.","year":"2022","unstructured":"Yang Y.; Hao W.; Wei T.; Tang L.; Qian N.; Yang Y.; Xi H.; Zhang S.; Yang W.; Role of serum ceruloplasmin in the diagnosis of Wilson\u2019s disease: A large Chinese study. Front Neurol 2022,13,1058642","journal-title":"Front Neurol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","volume":"369","author":"Ala A.","year":"2007","unstructured":"Ala A.; Walker A.P.; Ashkan K.; Dooley J.S.; Schilsky M.L.; Wilson\u2019s disease. Lancet 2007,369(9559),397-408","journal-title":"Lancet"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/BST0361233","volume":"36","author":"Lutsenko S.","year":"2008","unstructured":"Lutsenko S.; Atp7b \u2212\/\u2212 mice as a model for studies of Wilson\u2019s disease. Biochem Soc Trans 2008,36(6),1233-1238","journal-title":"Biochem Soc Trans"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1172\/JCI78991","volume":"125","author":"Wooton-Kee C.R.","year":"2015","unstructured":"Wooton-Kee C.R.; Jain A.K.; Wagner M.; Grusak M.A.; Finegold M.J.; Lutsenko S.; Moore D.D.; Elevated copper impairs hepatic nuclear receptor function in Wilson\u2019s disease. J Clin Invest 2015,125(9),3449-3460","journal-title":"J Clin Invest"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1136\/jnnp-2021-326123","volume":"92","author":"Shribman S.","year":"2021","unstructured":"Shribman S.; Poujois A.; Bandmann O.; Czlonkowska A.; Warner T.T.; Wilson\u2019s disease: update on pathogenesis, biomarkers and treatments. J Neurol Neurosurg Psychiatry 2021,92(10),1053-1061","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nyas.12347","volume":"1315","author":"Zischka H.","year":"2014","unstructured":"Zischka H.; Lichtmannegger J.; Pathological mitochondrial copper overload in livers of Wilson\u2019s disease patients and related animal models. Ann N Y Acad Sci 2014,1315(1),6-15","journal-title":"Ann N Y Acad Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2013.03.021","volume":"329","author":"Litwin T.","year":"2013","unstructured":"Litwin T.; Gromadzka G.; Szpak G.M.; Jab\u0142onka-Salach, K.; Bulska, E.; Cz\u0142onkowska, A. Brain metal accumulation in Wilson\u2019s disease. J Neurol Sci 2013,329(1-2),55-58","journal-title":"J Neurol Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/15563650701502535","volume":"45","author":"Lech T.","year":"2007","unstructured":"Lech T.; Hydzik P.; Kosowski B.; Significance of copper determination in late onset of Wilson\u2019s disease. Clin Toxicol (Phila) 2007,45(6),688-694","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/0016-5085(94)90822-2","volume":"107","author":"Sokol R.J.","year":"1994","unstructured":"Sokol R.J.; Twedt D.; McKim J.M.; Devereaux M.W.; Karrer F.M.; Kam I.; Von Steigman G.; Narkewicz M.R.; Bacon B.R.; Britton R.S.; Neuschwander-Tetri B.A.; Oxidant injury to hepatic mitochondria in patients with Wilson\u2019s disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994,107(6),1788-1798","journal-title":"Gastroenterology"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.trsl.2009.05.002","volume":"154","author":"Brewer G.J.","year":"2009","unstructured":"Brewer G.J.; Askari F.; Dick R.B.; Sitterly J.; Fink J.K.; Carlson M.; Kluin K.J.; Lorincz M.T.; Treatment of Wilson\u2019s disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine. Transl Res 2009,154(2),70-77","journal-title":"Transl Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/humu.22266","volume":"34","author":"T&#xFC;mer Z.","year":"2013","unstructured":"T&#xFC;mer Z.; An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome. Hum Mutat 2013,34(3),417-429","journal-title":"Hum Mutat"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/mt.2011.143","volume":"19","author":"Donsante A.","year":"2011","unstructured":"Donsante A.; Yi L.; Zerfas P.M.; Brinster L.R.; Sullivan P.; Goldstein D.S.; Prohaska J.; Centeno J.A.; Rushing E.; Kaler S.G.; ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model. Mol Ther 2011,19(12),2114-2123","journal-title":"Mol Ther"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00018-007-7439-6","volume":"65","author":"Bertini I.","year":"2008","unstructured":"Bertini I.; Rosato A.; Menkes disease. Cell Mol Life Sci 2008,65(1),89-91","journal-title":"Cell Mol Life Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fnmol.2015.00072","volume":"8","author":"Lenartowicz M.","year":"2015","unstructured":"Lenartowicz M.; Krzeptowski W.; Lipi\u0144ski, P.; Grzmil, P.; Starzy\u0144ski, R.; Pierzcha\u0142a, O.; M&#xF8;ller, L.B. Mottled mice and non-mammalian models of Menkes disease. Front Mol Neurosci 2015,8,72","journal-title":"Front Mol Neurosci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1021\/acs.molpharmaceut.7b00841","volume":"15","author":"Giampietro R.","year":"2018","unstructured":"Giampietro R.; Spinelli F.; Contino M.; Colabufo N.A.; The pivotal role of copper in neurodegeneration: A new strategy for the therapy of neurodegenerative disorders. Mol Pharm 2018,15(3),808-820","journal-title":"Mol Pharm"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/biomedicines9040391","volume":"9","author":"Horn N.","year":"2021","unstructured":"Horn N.; Wittung-Stafshede P.; ATP7A-regulated enzyme metalation and trafficking in the Menkes disease puzzle. Biomedicines 2021,9(4),391","journal-title":"Biomedicines"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"e09268","DOI":"10.1016\/j.heliyon.2022.e09268","volume":"8","author":"Guo Y.","year":"2022","unstructured":"Guo Y.; Xia W.; Peng X.; Shao J.; Almost misdiagnosed Menkes disease: A case report. Heliyon 2022,8(4),e09268","journal-title":"Heliyon"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1172\/JCI90605","volume":"127","author":"Aguzzi A.","year":"2017","unstructured":"Aguzzi A.; Zhu C.; Microglia in prion diseases. J Clin Invest 2017,127(9),3230-3239","journal-title":"J Clin Invest"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.neuro.2006.06.004","volume":"27","author":"Choi C.J.","year":"2006","unstructured":"Choi C.J.; Kanthasamy A.; Anantharam V.; Kanthasamy A.G.; Interaction of metals with prion protein: Possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 2006,27(5),777-787","journal-title":"Neurotoxicology"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1474-4422(05)70192-7","volume":"4","author":"Johnson R.T.","year":"2005","unstructured":"Johnson R.T.; Prion diseases. Lancet Neurol 2005,4(10),635-642","journal-title":"Lancet Neurol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00401-004-0953-9","volume":"109","author":"Unterberger U.","year":"2005","unstructured":"Unterberger U.; Voigtl&#xE4;nder T.; Budka H.; Pathogenesis of prion diseases. Acta Neuropathol 2005,109(1),32-48","journal-title":"Acta Neuropathol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/ijms22031267","volume":"22","author":"Kawahara M.","year":"2021","unstructured":"Kawahara M.; Kato-Negishi M.; Tanaka K.; Neurometals in the pathogenesis of Prion diseases. Int J Mol Sci 2021,22(3),1267","journal-title":"Int J Mol Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1007\/PL00014175","volume":"249","author":"Kretzschmar H.A.","year":"1999","unstructured":"Kretzschmar H.A.; Molecular pathogenesis of prion diseases. Eur Arch Psychiatry Clin Neurosci 1999,249(S3)(Suppl. 3),S56-S63","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nri3553","volume":"13","author":"Aguzzi A.","year":"2013","unstructured":"Aguzzi A.; Nuvolone M.; Zhu C.; The immunobiology of prion diseases. Nat Rev Immunol 2013,13(12),888-902","journal-title":"Nat Rev Immunol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molmed.2010.09.001","volume":"17","author":"Soto C.","year":"2011","unstructured":"Soto C.; Satani N.; The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 2011,17(1),14-24","journal-title":"Trends Mol Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nrmicro1492","volume":"4","author":"Aguzzi A.","year":"2006","unstructured":"Aguzzi A.; Heikenwalder M.; Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol 2006,4(10),765-775","journal-title":"Nat Rev Microbiol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1046\/j.1471-4159.2001.00522.x","volume":"78","author":"Wong B.S.","year":"2001","unstructured":"Wong B.S.; Chen S.G.; Colucci M.; Xie Z.; Pan T.; Liu T.; Li R.; Gambetti P.; Sy M.S.; Brown D.R.; Aberrant metal binding by prion protein in human prion disease. J Neurochem 2001,78(6),1400-1408","journal-title":"J Neurochem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/S1466252307001181","volume":"7","author":"Leach S.P.","year":"2006","unstructured":"Leach S.P.; Salman M.D.; Hamar D.; Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein. Anim Health Res Rev 2006,7(1-2),97-105","journal-title":"Anim Health Res Rev"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1007\/s12035-019-1505-6","volume":"56","author":"Meneghetti E.","year":"2019","unstructured":"Meneghetti E.; Gasperini L.; Virgilio T.; Moda F.; Tagliavini F.; Benetti F.; Legname G.; Prions strongly reduce NMDA receptor s-nitrosylation levels at pre-symptomatic and terminal stages of Prion diseases. Mol Neurobiol 2019,56(9),6035-6045","journal-title":"Mol Neurobiol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/mrc.3936","volume":"51","author":"Emwas A.H.M.","year":"2013","unstructured":"Emwas A.H.M.; Al-Talla Z.A.; Guo X.; Al-Ghamdi S.; Al-Masri H.T.; Utilizing NMR and EPR spectroscopy to probe the role of copper in prion diseases. Magn Reson Chem 2013,51(5),255-268","journal-title":"Magn Reson Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.2174\/138161206777698873","volume":"12","author":"Varela-Nallar L.","year":"2006","unstructured":"Varela-Nallar L.; Gonz&#xE1;lez A.; Inestrosa N.; Role of copper in prion diseases: deleterious or beneficial? Curr Pharm Des 2006,12(20),2587-2595","journal-title":"Curr Pharm Des"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1367-5931(02)00295-8","volume":"6","author":"Lehmann S.","year":"2002","unstructured":"Lehmann S.; Metal ions and prion diseases. Curr Opin Chem Biol 2002,6(2),187-192","journal-title":"Curr Opin Chem Biol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1007\/s10072-020-04321-9","volume":"41","author":"Alsiary R.A.","year":"2020","unstructured":"Alsiary R.A.; Alghrably M.; Saoudi A.; Al-Ghamdi S.; Jaremko L.; Jaremko M.; Emwas A.H.; Using NMR spectroscopy to investigate the role played by copper in prion diseases. Neurol Sci 2020,41(9),2389-2406","journal-title":"Neurol Sci"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0048-9697(02)00140-7","volume":"297","author":"Bounias M.","year":"2002","unstructured":"Bounias M.; Purdey M.; Transmissible spongiform encephalopathies: a family of etiologically complex diseases\u2014a review. Sci Total Environ 2002,297(1-3),1-19","journal-title":"Sci Total Environ"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","volume":"20","author":"Bar-Or A.","year":"2021","unstructured":"Bar-Or A.; Li R.; Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol 2021,20(6),470-483","journal-title":"Lancet Neurol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","volume":"21","author":"Bierhansl L.","year":"2022","unstructured":"Bierhansl L.; Hartung H.P.; Aktas O.; Ruck T.; Roden M.; Meuth S.G.; Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Discov 2022,21(8),578-600","journal-title":"Nat Rev Drug Discov"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"e2025804118","DOI":"10.1073\/pnas.2025804118","volume":"118","author":"Colombo E.","year":"2021","unstructured":"Colombo E.; Triolo D.; Bassani C.; Bedogni F.; Di Dario M.; Dina G.; Fredrickx E.; Fermo I.; Martinelli V.; Newcombe J.; Taveggia C.; Quattrini A.; Comi G.; Farina C.; Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes. Proc Natl Acad Sci USA 2021,118(27),e2025804118","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s40520-019-01463-5","volume":"33","author":"Malosio M.L.","year":"2021","unstructured":"Malosio M.L.; Tecchio F.; Squitti R.; Molecular mechanisms underlying copper function and toxicity in neurons and their possible therapeutic exploitation for Alzheimer\u2019s disease. Aging Clin Exp Res 2021,33(7),2027-2030","journal-title":"Aging Clin Exp Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-019-01964-7","volume":"137","author":"Burk K.","year":"2019","unstructured":"Burk K.; Pasterkamp R.J.; Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol 2019,137(6),859-877","journal-title":"Acta Neuropathol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"126779","DOI":"10.1016\/j.jtemb.2021.126779","volume":"67","author":"Fasae K.D.","year":"2021","unstructured":"Fasae K.D.; Abolaji A.O.; Faloye T.R.; Odunsi A.Y.; Oyetayo B.O.; Enya J.I.; Rotimi J.A.; Akinyemi R.O.; Whitworth A.J.; Aschner M.; Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer\u2019s disease: Limitations, and current and future perspectives. J Trace Elem Med Biol 2021,67,126779","journal-title":"J Trace Elem Med Biol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.1039\/C4CS00138A","volume":"43","author":"Barnham K.J.","year":"2014","unstructured":"Barnham K.J.; Bush A.I.; Biological metals and metal-targeting compounds in major neurodegenerative diseases. Chem Soc Rev 2014,43(19),6727-6749","journal-title":"Chem Soc Rev"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s11011-021-00765-w","volume":"36","author":"Das N.","year":"2021","unstructured":"Das N.; Raymick J.; Sarkar S.; Role of metals in Alzheimer\u2019s disease. Metab Brain Dis 2021,36(7),1627-1639","journal-title":"Metab Brain Dis"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/CS20150153","volume":"130","author":"Davies K.M.","year":"2016","unstructured":"Davies K.M.; Mercer J.F.B.; Chen N.; Double K.L.; Copper dyshomoeostasis in Parkinson\u2019s disease: implications for pathogenesis and indications for novel therapeutics. Clin Sci (Lond) 2016,130(8),565-574","journal-title":"Clin Sci (Lond)"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1474-4422(14)70262-5","volume":"14","year":"2015","unstructured":"Safety, tolerability, and efficacy of PBT2 in Huntington\u2019s disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2015,14(1),39-47","journal-title":"Lancet Neurol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.nbd.2013.01.012","volume":"54","author":"Choi B.Y.","year":"2013","unstructured":"Choi B.Y.; Jang B.G.; Kim J.H.; Seo J.N.; Wu G.; Sohn M.; Chung T.N.; Suh S.W.; Copper\/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model. Neurobiol Dis 2013,54,382-391","journal-title":"Neurobiol Dis"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00775-009-0600-y","volume":"15","author":"Hung Y.H.","year":"2010","unstructured":"Hung Y.H.; Bush A.I.; Cherny R.A.; Copper in the brain and Alzheimer\u2019s disease. J Biol Inorg Chem 2010,15(1),61-76","journal-title":"J Biol Inorg Chem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1365-2362.2002.00933.x","volume":"32","author":"Squitti R.","year":"2002","unstructured":"Squitti R.; Rossini P.M.; Cassetta E.; Moffa F.; Pasqualetti P.; Cortesi M.; Colloca A.; Rossi L.; Finazzi-Agr&#xF3; A.; d-penicillamine reduces serum oxidative stress in Alzheimer\u2019s disease patients. Eur J Clin Invest 2002,32(1),51-59","journal-title":"Eur J Clin Invest"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.jhep.2004.11.013","volume":"42","author":"Brewer G.J.","year":"2005","unstructured":"Brewer G.J.; Askari F.K.; Wilson's disease: Clinical management and therapy. J Hepatol 2005,42(Suppl(1)),S13-S21","journal-title":"J Hepatol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2967\/jnumed.113.131797","volume":"55","author":"Nomura S.","year":"2014","unstructured":"Nomura S.; Nozaki S.; Hamazaki T.; Takeda T.; Ninomiya E.; Kudo S.; Hayashinaka E.; Wada Y.; Hiroki T.; Fujisawa C.; Kodama H.; Shintaku H.; Watanabe Y.; PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model. J Nucl Med 2014,55(5),845-851","journal-title":"J Nucl Med"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/acschemneuro.0c00621","volume":"12","author":"Zhao J.","year":"2021","unstructured":"Zhao J.; Shi Q.; Tian H.; Li Y.; Liu Y.; Xu Z.; Robert A.; Liu Q.; Meunier B.; TDMQ20, a specific copper chelator, reduces memory impairments in Alzheimer\u2019s disease mouse models. ACS Chem Neurosci 2021,12(1),140-149","journal-title":"ACS Chem Neurosci"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ejhg.2009.187","volume":"18","author":"T&#xFC;mer Z.","year":"2010","unstructured":"T&#xFC;mer Z.; M&#xF8;ller L.B.; Menkes disease. Eur J Hum Genet 2010,18(5),511-518","journal-title":"Eur J Hum Genet"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1039\/C6MT00101G","volume":"8","author":"Squitti R.","year":"2016","unstructured":"Squitti R.; Siotto M.; Arciello M.; Rossi L.; Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer\u2019s disease. Metallomics 2016,8(9),863-873","journal-title":"Metallomics"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-0037-1602764","volume":"37","author":"Lalioti V.","year":"2017","unstructured":"Lalioti V.; Tsubota A.; Sandoval I.; Disorders in hepatic copper secretion: Wilson\u2019s disease and pleomorphic syndromes. Semin Liver Dis 2017,37(2),175-188","journal-title":"Semin Liver Dis"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-319-60189-2_10","volume":"18","author":"Mathys Z.K.","year":"2017","unstructured":"Mathys Z.K.; White A.R.; Copper and Alzheimer\u2019s disease. Adv Neurobiol 2017,18,199-216","journal-title":"Adv Neurobiol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"30269","DOI":"10.1038\/srep30269","volume":"6","author":"Ellett L.J.","year":"2016","unstructured":"Ellett L.J.; Hung L.W.; Munckton R.; Sherratt N.A.; Culvenor J.; Grubman A.; Furness J.B.; White A.R.; Finkelstein D.I.; Barnham K.J.; Lawson V.A.; Restoration of intestinal function in an MPTP model of Parkinson\u2019s Disease. Sci Rep 2016,6(1),30269","journal-title":"Sci Rep"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2017.09.032","volume":"660","author":"Abbaoui A.","year":"2017","unstructured":"Abbaoui A.; Chatoui H.; El Hiba O.; Gamrani H.; Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson\u2019s disease. Neurosci Lett 2017,660,103-108","journal-title":"Neurosci Lett"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","volume":"34","author":"Roberts B.R.","year":"2014","unstructured":"Roberts B.R.; Lim N.K.H.; McAllum E.J.; Donnelly P.S.; Hare D.J.; Doble P.A.; Turner B.J.; Price K.A.; Chun Lim S.; Paterson B.M.; Hickey J.L.; Rhoads T.W.; Williams J.R.; Kanninen K.M.; Hung L.W.; Liddell J.R.; Grubman A.; Monty J.F.; Llanos R.M.; Kramer D.R.; Mercer J.F.B.; Bush A.I.; Masters C.L.; Duce J.A.; Li Q.X.; Beckman J.S.; Barnham K.J.; White A.R.; Crouch P.J.; Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 2014,34(23),8021-8031","journal-title":"J Neurosci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/ijms17050636","volume":"17","author":"Tokuda E.","year":"2016","unstructured":"Tokuda E.; Furukawa Y.; Copper homeostasis as a therapeutic target in amyotrophic lateral sclerosis with sod1 mutations. Int J Mol Sci 2016,17(5),636","journal-title":"Int J Mol Sci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1126\/science.aaz8899","volume":"368","author":"Guthrie L.M.","year":"2020","unstructured":"Guthrie L.M.; Soma S.; Yuan S.; Silva A.; Zulkifli M.; Snavely T.C.; Greene H.F.; Nunez E.; Lynch B.; De Ville C.; Shanbhag V.; Lopez F.R.; Acharya A.; Petris M.J.; Kim B.E.; Gohil V.M.; Sacchettini J.C.; Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice. Science 2020,368(6491),620-625","journal-title":"Science"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/biof.1687","volume":"47","author":"Kempuraj D.","year":"2021","unstructured":"Kempuraj D.; Thangavel R.; Kempuraj D.D.; Ahmed M.E.; Selvakumar G.P.; Raikwar S.P.; Zaheer S.A.; Iyer S.S.; Govindarajan R.; Chandrasekaran P.N.; Zaheer A.; Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors 2021,47(2),190-197","journal-title":"Biofactors"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.lfs.2017.10.041","volume":"193","author":"Liu Q.S.","year":"2018","unstructured":"Liu Q.S.; Jiang H.L.; Wang Y.; Wang L.L.; Zhang J.X.; He C.H.; Shao S.; Zhang T.T.; Xing J.G.; Liu R.; Total flavonoid extract from Dracoephalum moldavica L. attenuates &#x3B2;-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways. Life Sci 2018,193,214-225","journal-title":"Life Sci"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/molecules16032084","volume":"16","author":"Liu R.","year":"2011","unstructured":"Liu R.; Meng F.; Zhang L.; Liu A.; Qin H.; Lan X.; Li L.; Du G.; Luteolin isolated from the medicinal plant Elsholtzia rugulosa (Labiatae) prevents copper-mediated toxicity in &#x3B2;-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Molecules 2011,16(3),2084-2096","journal-title":"Molecules"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1021\/acs.jpcb.9b10531","volume":"124","author":"Xu Y.","year":"2020","unstructured":"Xu Y.; Yang J.; Lu Y.; Qian L.L.; Yang Z.Y.; Han R.M.; Zhang J.P.; Skibsted L.H.; Copper(II) coordination and translocation in luteolin and effect on radical scavenging. J Phys Chem B 2020,124(2),380-388","journal-title":"J Phys Chem B"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.3390\/molecules18089949","volume":"18","author":"Zhao L.","year":"2013","unstructured":"Zhao L.; Wang J.L.; Liu R.; Li X.X.; Li J.F.; Zhang L.; Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer\u2019s disease mouse model. Molecules 2013,18(8),9949-9965","journal-title":"Molecules"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainres.2012.11.019","volume":"1492","author":"Zhao L.","year":"2013","unstructured":"Zhao L.; Wang J.; Wang Y.; Fa X.; Apigenin attenuates copper-mediated &#x3B2;-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model. Brain Res 2013,1492,33-45","journal-title":"Brain Res"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.1007\/s11356-014-2747-5","volume":"21","author":"Peng H.","year":"2014","unstructured":"Peng H.; Xing Y.; Gao L.; Zhang L.; Zhang G.; Simultaneous separation of apigenin, luteolin and rosmarinic acid from the aerial parts of the copper-tolerant plant Elsholtzia splendens. Environ Sci Pollut Res Int 2014,21(13),8124-8132","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/JAD-190640","volume":"72","author":"Wang Q.","year":"2019","unstructured":"Wang Q.; Jiang H.; Wang L.; Yi H.; Li Z.; Liu R.; Vitegnoside mitigates neuronal injury, mitochondrial apoptosis, and inflammation in an Alzheimer\u2019s disease cell model via the p38 MAPK\/JNK Pathway. J Alzheimers Dis 2019,72(1),199-214","journal-title":"J Alzheimers Dis"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.3390\/molecules26206128","volume":"26","author":"Lin M.C.","year":"2021","unstructured":"Lin M.C.; Liu C.C.; Liao C.S.; Ro J.H.; Neuroprotective effect of quercetin during cerebral ischemic injury involves regulation of essential elements, transition metals, cu\/zn ratio, and antioxidant activity. Molecules 2021,26(20),6128","journal-title":"Molecules"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8825387","volume":"2020","author":"Yang D.","year":"2020","unstructured":"Yang D.; Wang T.; Long M.; Li P.; Quercetin: its main pharmacological activity and potential application in clinical medicine. Oxid Med Cell Longev 2020,2020,1-13","journal-title":"Oxid Med Cell Longev"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.3892\/mmr.2018.8801","volume":"17","author":"Du G.","year":"2018","unstructured":"Du G.; Zhao Z.; Chen Y.; Li Z.; Tian Y.; Liu Z.; Liu B.; Song J.; Quercetin protects rat cortical neurons against traumatic brain injury. Mol Med Rep 2018,17(6),7859-7865","journal-title":"Mol Med Rep"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.fct.2017.10.042","volume":"110","author":"Jomova K.","year":"2017","unstructured":"Jomova K.; Lawson M.; Drostinova L.; Lauro P.; Poprac P.; Brezova V.; Michalik M.; Lukes V.; Valko M.; Protective role of quercetin against copper(II)-induced oxidative stress: A spectroscopic, theoretical and DNA damage study. Food Chem Toxicol 2017,110,340-350","journal-title":"Food Chem Toxicol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1007\/s12011-022-03093-x","volume":"200","author":"Chakraborty J.","year":"2022","unstructured":"Chakraborty J.; Pakrashi S.; Sarbajna A.; Dutta M.; Bandyopadhyay J.; Quercetin attenuates copper-induced apoptotic cell death and endoplasmic reticulum stress in SH-SY5Y cells by autophagic modulation. Biol Trace Elem Res 2022,200(12),5022-5041","journal-title":"Biol Trace Elem Res"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9834742","volume":"2020","year":"2020","unstructured":"Zub&#x10D;i\u0107 K.; Radovanovi\u0107 V.; Vlaini\u0107 J.; Hof, P.R.; Or\u0161oli\u0107 N.; \u0160imi\u0107 G.; Jazvin\u0161\u0107ak Jembrek, M. PI3K\/Akt and ERK1\/2 signalling are involved in quercetin-mediated neuroprotection against copper-induced injury. Oxid Med Cell Longev 2020,2020,1-14","journal-title":"Oxid Med Cell Longev"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1385\/BTER:84:1-3:001","volume":"84","author":"Kuo S.M.","year":"2001","unstructured":"Kuo S.M.; Huang C.T.; Blum P.; Chang C.; Quercetin cumulatively enhances copper induction of metallothionein in intestinal cells. Biol Trace Elem Res 2001,84(1-3),001-010","journal-title":"Biol Trace Elem Res"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/10408398.2016.1231168","volume":"58","author":"Gan R.Y.","year":"2018","unstructured":"Gan R.Y.; Li H.B.; Sui Z.Q.; Corke H.; Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Crit Rev Food Sci Nutr 2018,58(6),924-941","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/bph.12009","volume":"168","author":"Steinmann J.","year":"2013","unstructured":"Steinmann J.; Buer J.; Pietschmann T.; Steinmann E.; Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol 2013,168(5),1059-1073","journal-title":"Br J Pharmacol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2005.10.056","volume":"395","author":"Koh S.H.","year":"2006","unstructured":"Koh S.H.; Lee S.M.; Kim H.Y.; Lee K.Y.; Lee Y.J.; Kim H.T.; Kim J.; Kim M.H.; Hwang M.S.; Song C.; Yang K.W.; Lee K.W.; Kim S.H.; Kim O.H.; The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci Lett 2006,395(2),103-107","journal-title":"Neurosci Lett"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3390\/molecules24162940","volume":"24","author":"Teng Y.","year":"2019","unstructured":"Teng Y.; Zhao J.; Ding L.; Ding Y.; Zhou P.; Complex of EGCG with Cu(II) suppresses amyloid aggregation and Cu(II)-induced cytotoxicity of alpha-synuclein. Molecules 2019,24(16),2940","journal-title":"Molecules"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"797298","DOI":"10.3389\/fphar.2021.797298","volume":"12","author":"Li J.","year":"2021","unstructured":"Li J.; Xiang H.; Huang C.; Lu J.; Pharmacological actions of myricetin in the nervous system: a comprehensive review of preclinical studies in animals and cell models. Front Pharmacol 2021,12,797298","journal-title":"Front Pharmacol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/758097","volume":"2012","author":"Zhang X.H.","year":"2012","unstructured":"Zhang X.H.; Ma Z.G.; Rowlands D.K.; Gou Y.L.; Fok K.L.; Wong H.Y.; Yu M.K.; Tsang L.L.; Mu L.; Chen L.; Yung W.H.; Chung Y.W.; Zhang B.L.; Zhao H.; Chan H.C.; Flavonoid myricetin modulates GABA(A) receptor activity through activation of Ca(2+) channels and CaMK-II pathway. Evid Based Complement Alternat Med 2012,2012,1-10","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/jsfa.5924","volume":"93","author":"Ding P.","year":"2013","unstructured":"Ding P.; Liao X.; Shi B.; Adsorption chromatography separation of the flavonols kaempferol, quercetin and myricetin using cross-linked collagen fibre as the stationary phase. J Sci Food Agric 2013,93(7),1575-1583","journal-title":"J Sci Food Agric"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/cbic.201000790","volume":"12","author":"DeToma A.S.","year":"2011","unstructured":"DeToma A.S.; Choi J.S.; Braymer J.J.; Lim M.H.; Myricetin: a naturally occurring regulator of metal-induced amyloid-&#x3B2; aggregation and neurotoxicity. ChemBioChem 2011,12(8),1198-1201","journal-title":"ChemBioChem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11064-020-03173-1","volume":"46","author":"Xiang B.","year":"2021","unstructured":"Xiang B.; Li D.; Chen Y.; Li M.; Zhang Y.; Sun T.; Tang S.; Curcumin ameliorates copper-induced neurotoxicity through inhibiting oxidative stress and mitochondrial apoptosis in SH-SY5Y cells. Neurochem Res 2021,46(2),367-378","journal-title":"Neurochem Res"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.toxrep.2020.01.015","volume":"7","author":"Abolaji A.O.","year":"2020","unstructured":"Abolaji A.O.; Fasae K.D.; Iwezor C.E.; Aschner M.; Farombi E.O.; Curcumin attenuates copper-induced oxidative stress and neurotoxicity in Drosophila melanogaster. Toxicol Rep 2020,7,261-268","journal-title":"Toxicol Rep"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.5530\/pj.2019.11.232","volume":"11","author":"RA Mans D.","year":"2019","unstructured":"RA Mans D.; Djotaroeno, M.; Friperson, P.; Pawirodihardjo, J. Phytochemical and pharmacological support for the traditional uses of Zingiberacea species in suriname - a review of the literature. Pharmacogn J 2019,11(6s),1511-1525","journal-title":"Pharmacogn J"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jchemneu.2019.01.001","volume":"96","author":"Abbaoui A.","year":"2019","unstructured":"Abbaoui A.; Gamrani H.; Obvious anxiogenic-like effects of subchronic copper intoxication in rats, outcomes on spatial learning and memory and neuromodulatory potential of curcumin. J Chem Neuroanat 2019,96,86-93","journal-title":"J Chem Neuroanat"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"113197","DOI":"10.1016\/j.biopha.2022.113197","volume":"152","author":"Ho W.I.","year":"2022","unstructured":"Ho W.I.; Hu Y.; Cheng C.W.; Wei R.; Yang J.; Li N.; Au K.W.; Tse Y.L.; Wang Q.; Ng K.M.; Esteban M.A.; Tse H.F.; Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson\u2019s disease. Biomed Pharmacother 2022,152,113197","journal-title":"Biomed Pharmacother"},{"key":"ref=176","first-page":"310","volume":"19","author":"Motavaf M.","year":"2020","unstructured":"Motavaf M.; Sadeghizadeh M.; Babashah S.; Zare L.; Javan M.; Protective effects of a nano-formulation of curcumin against cuprizone-induced demyelination in the mouse corpus callosum. Iran J Pharm Res 2020,19(3),310-320","journal-title":"Iran J Pharm Res"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.fct.2011.04.004","volume":"49","author":"Huang H.C.","year":"2011","unstructured":"Huang H.C.; Lin C.J.; Liu W.J.; Jiang R.R.; Jiang Z.F.; Dual effects of curcumin on neuronal oxidative stress in the presence of Cu(II). Food Chem Toxicol 2011,49(7),1578-1583","journal-title":"Food Chem Toxicol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.3390\/molecules26185591","volume":"26","author":"Sarawi W.S.","year":"2021","unstructured":"Sarawi W.S.; Alhusaini A.M.; Fadda L.M.; Alomar H.A.; Albaker A.B.; Aljrboa A.S.; Alotaibi A.M.; Hasan I.H.; Mahmoud A.M.; Curcumin and Nano-curcumin mitigate copper neurotoxicity by modulating oxidative stress, inflammation, and Akt\/GSK-3beta signaling. Molecules 2021,26(18),5591","journal-title":"Molecules"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.acthis.2018.06.005","volume":"120","author":"Abbaoui A.","year":"2018","unstructured":"Abbaoui A.; Gamrani H.; Neuronal, astroglial and locomotor injuries in subchronic copper intoxicated rats are repaired by curcumin: A possible link with Parkinson\u2019s disease. Acta Histochem 2018,120(6),542-550","journal-title":"Acta Histochem"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.neulet.2008.05.070","volume":"440","author":"Lin R.","year":"2008","unstructured":"Lin R.; Chen X.; Li W.; Han Y.; Liu P.; Pi R.; Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: Blockage by curcumin. Neurosci Lett 2008,440(3),344-347","journal-title":"Neurosci Lett"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6241017","volume":"2018","author":"Enogieru A.B.","year":"2018","unstructured":"Enogieru A.B.; Haylett W.; Hiss D.C.; Bardien S.; Ekpo O.E.; Rutin as a Potent antioxidant: implications for neurodegenerative disorders. Oxid Med Cell Longev 2018,2018,1-17","journal-title":"Oxid Med Cell Longev"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"e22623","DOI":"10.1002\/jbt.22623","volume":"35","author":"Arowoogun J.","year":"2021","unstructured":"Arowoogun J.; Akanni O.O.; Adefisan A.O.; Owumi S.E.; Tijani A.S.; Adaramoye O.A.; Rutin ameliorates copper sulfate\u2010induced brain damage via antioxidative and anti\u2010inflammatory activities in rats. J Biochem Mol Toxicol 2021,35(1),e22623","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3390\/antiox10101515","volume":"10","author":"Lin M.C.","year":"2021","unstructured":"Lin M.C.; Liu C.C.; Lin Y.C.; Liao C.S.; Resveratrol protects against cerebral ischemic injury via restraining lipid peroxidation, transition elements, and toxic metal levels, but enhancing anti-oxidant activity. Antioxidants 2021,10(10),1515","journal-title":"Antioxidants"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12263-012-0319-1","volume":"8","author":"Tian C.","year":"2013","unstructured":"Tian C.; Zhang R.; Ye X.; Zhang C.; Jin X.; Yamori Y.; Hao L.; Sun X.; Ying C.; Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF\/KDR pathway. Genes Nutr 2013,8(2),231-239","journal-title":"Genes Nutr"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"114877","DOI":"10.1016\/j.taap.2020.114877","volume":"390","author":"Majewski M.","year":"2020","unstructured":"Majewski M.; Ognik K.; Thoene M.; Rawicka A.; Ju&#x15B;kiewicz, J. Resveratrol modulates the blood plasma levels of Cu and Zn, the antioxidant status and the vascular response of thoracic arteries in copper deficient Wistar rats. Toxicol Appl Pharmacol 2020,390,114877","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"3793817","DOI":"10.1155\/2017\/3793817","volume":"2017","author":"Matos L.","year":"2017","unstructured":"Matos L.; Gouveia A.M.; Almeida H.; Resveratrol attenuates copper-induced senescence by improving cellular proteostasis. Oxid Med Cell Longev 2017,2017,3793817","journal-title":"Oxid Med Cell Longev"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12011-016-0861-6","volume":"177","author":"Asadi S.","year":"2017","unstructured":"Asadi S.; Moradi M.N.; Khyripour N.; Goodarzi M.T.; Mahmoodi M.; Resveratrol attenuates copper and zinc homeostasis and ameliorates oxidative stress in Type 2 diabetic rats. Biol Trace Elem Res 2017,177(1),132-138","journal-title":"Biol Trace Elem Res"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jtemb.2019.06.013","volume":"55","author":"Muselin F.","year":"2019","unstructured":"Muselin F.; G&#xE2;rban Z.; Cristina R.T.; Doma A.O.; Dumitrescu E.; Vi&#x21B;\u0103laru, A.B.; B\u0103n\u0103&#x21B;ean-Dunea, I. Homeostatic changes of some trace elements in geriatric rats in the condition of oxidative stress induced by aluminum and the beneficial role of resveratrol. J Trace Elem Med Biol 2019,55,136-142","journal-title":"J Trace Elem Med Biol"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.pharep.2019.03.011","volume":"71","author":"Majewski M.","year":"2019","unstructured":"Majewski M.; Ognik K.; Ju&#x15B;kiewicz, J. The interaction between resveratrol and two forms of copper as carbonate and nanoparticles on antioxidant mechanisms and vascular function in Wistar rats. Pharmacol Rep 2019,71(5),862-869","journal-title":"Pharmacol Rep"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00210-018-1526-0","volume":"391","author":"Khalid S.","year":"2018","unstructured":"Khalid S.; Afzal N.; Khan J.A.; Hussain Z.; Qureshi A.S.; Anwar H.; Jamil Y.; Antioxidant resveratrol protects against copper oxide nanoparticle toxicity in vivo. Naunyn Schmiedebergs Arch Pharmacol 2018,391(10),1053-1062","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"17519","DOI":"10.1021\/acs.inorgchem.0c02754","volume":"59","author":"Summers K.L.","year":"2020","unstructured":"Summers K.L.; Roseman G.P.; Sopasis G.J.; Millhauser G.L.; Harris H.H.; Pickering I.J.; George G.N.; Copper(II) binding to pbt2 differs from that of other 8-hydroxyquinoline chelators: implications for the treatment of neurodegenerative protein misfolding diseases. Inorg Chem 2020,59(23),17519-17534","journal-title":"Inorg Chem"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/ene.12320","volume":"21","year":"2014","unstructured":"Dzie&#x17C;yc, K.; Karli\u0144ski, M.; Litwin, T.; Cz\u0142onkowska, A. Compliant treatment with anti-copper agents prevents clinically overt Wilson\u2019s disease in pre-symptomatic patients. Eur J Neurol 2014,21(2),332-337","journal-title":"Eur J Neurol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJMoa070613","volume":"358","author":"Kaler S.G.","year":"2008","unstructured":"Kaler S.G.; Holmes C.S.; Goldstein D.S.; Tang J.; Godwin S.C.; Donsante A.; Liew C.J.; Sato S.; Patronas N.; Neonatal diagnosis and treatment of Menkes disease. N Engl J Med 2008,358(6),605-614","journal-title":"N Engl J Med"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/biom9070269","volume":"9","author":"Tosato M.","year":"2019","unstructured":"Tosato M.; Di Marco V.; Metal chelation therapy and Parkinson\u2019s disease: a critical review on the thermodynamics of complex formation between relevant metal ions and promising or established drugs. Biomolecules 2019,9(7),269","journal-title":"Biomolecules"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"101795","DOI":"10.1016\/j.redox.2020.101795","volume":"38","author":"Gou D.H.","year":"2021","unstructured":"Gou D.H.; Huang T.T.; Li W.; Gao X.D.; Haikal C.; Wang X.H.; Song D.Y.; Liang X.; Zhu L.; Tang Y.; Ding C.; Li J.Y.; Inhibition of copper transporter 1 prevents &#x3B1;-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson\u2019s disease. Redox Biol 2021,38,101795","journal-title":"Redox Biol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"Chen L.","year":"2022","unstructured":"Chen L.; Min J.; Wang F.; Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther 2022,7(1),378","journal-title":"Signal Transduct Target Ther"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/414817","volume":"2013","author":"Arnal N.","year":"2013","unstructured":"Arnal N.; Morel G.R.; de Alaniz M.J.T.; Castillo O.; Marra C.A.; Role of copper and cholesterol association in the neurodegenerative process. Int J Alzheimers Dis 2013,2013,1-15","journal-title":"Int J Alzheimers Dis"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.omtm.2022.06.001","volume":"26","author":"Murillo O.","year":"2022","unstructured":"Murillo O.; Collantes M.; Gazquez C.; Moreno D.; Hernandez-Alcoceba R.; Barberia M.; Ecay M.; Tamarit B.; Douar A.; Ferrer V.; Combal J.P.; Pe&#xF1;uelas I.; B&#xE9;nichou B.; Gonzalez-Aseguinolaza G.; High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson\u2019s disease. Mol Ther Methods Clin Dev 2022,26,98-106","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/hep.32484","volume":"76","author":"Cai H.","year":"2022","unstructured":"Cai H.; Cheng X.; Wang X.P.; ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson\u2019s disease. Hepatology 2022,76(4),1046-1057","journal-title":"Hepatology"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1567202619666211223125628","volume":"18","author":"Du A.","year":"2021","unstructured":"Du A.; Cai R.; Shi J.; Wu Q.; Protective effects of icariin on traumatic brain injury. Curr Neurovasc Res 2021,18(5),508-514","journal-title":"Curr Neurovasc Res"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.acthis.2017.06.003","volume":"119","author":"Abbaoui A.","year":"2017","unstructured":"Abbaoui A.; Hiba O.E.; Gamrani H.; Neuroprotective potential of Aloe arborescens against copper induced neurobehavioral features of Parkinson\u2019s disease in rat. Acta Histochem 2017,119(5),592-601","journal-title":"Acta Histochem"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s12035-016-0363-8","volume":"55","author":"Pan C.","year":"2018","unstructured":"Pan C.; Liu N.; Zhang P.; Wu Q.; Deng H.; Xu F.; Lian L.; Liang Q.; Hu Y.; Zhu S.; Tang Z.; EGb761 ameliorates neuronal apoptosis and promotes angiogenesis in experimental intracerebral hemorrhage via RSK1\/GSK3beta pathway. Mol Neurobiol 2018,55(2),1556-1567","journal-title":"Mol Neurobiol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nut.2008.10.013","volume":"25","author":"Rojas P.","year":"2009","unstructured":"Rojas P.; Montes S.; Serrano-Garc&#xED;a N.; Rojas-Casta&#xF1;eda J.; Effect of EGb761 supplementation on the content of copper in mouse brain in an animal model of Parkinson\u2019s disease. Nutrition 2009,25(4),482-485","journal-title":"Nutrition"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"153346","DOI":"10.1016\/j.phymed.2020.153346","volume":"79","author":"Cao J.","year":"2020","unstructured":"Cao J.; Li C.; Ma P.; Ding Y.; Gao J.; Jia Q.; Zhu J.; Zhang T.; Effect of kaempferol on IgE-mediated anaphylaxis in C57BL\/6 mice and LAD2 cells. Phytomedicine 2020,79,153346","journal-title":"Phytomedicine"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/ijms22041619","volume":"22","author":"Simunkova M.","year":"2021","unstructured":"Simunkova M.; Barbierikova Z.; Jomova K.; Hudecova L.; Lauro P.; Alwasel S.H.; Alhazza I.; Rhodes C.J.; Valko M.; Antioxidant vs. Prooxidant properties of the flavonoid, kaempferol, in the presence of Cu(II) ions: a ros-scavenging activity, fenton reaction and dna damage study. Int J Mol Sci 2021,22(4),1619","journal-title":"Int J Mol Sci"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuint.2018.11.003","volume":"122","author":"Fachel F.N.S.","year":"2019","unstructured":"Fachel F.N.S.; Schuh R.S.; Veras K.S.; Bassani V.L.; Koester L.S.; Henriques A.T.; Braganhol E.; Teixeira H.F.; An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders. Neurochem Int 2019,122,47-58","journal-title":"Neurochem Int"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/life10070118","volume":"10","author":"Kola A.","year":"2020","unstructured":"Kola A.; Hecel A.; Lamponi S.; Valensin D.; Novel perspective on Alzheimer\u2019s disease treatment: rosmarinic acid molecular interplay with Copper(II) and amyloid beta. Life (Basel) 2020,10(7),118","journal-title":"Life (Basel)"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2174\/1570159X16666180911123341","volume":"17","author":"Costa I.M.","year":"2019","unstructured":"Costa I.M.; Lima F.O.V.; Fernandes L.C.B.; Norrara B.; Neta F.I.; Alves R.D.; Cavalcanti J.R.L.P.; Lucena E.E.S.; Cavalcante J.S.; Rego A.C.M.; Filho I.A.; Queiroz D.B.; Freire M.A.M.; Guzen F.P.; Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: a systematic review. Curr Neuropharmacol 2019,17(7),648-665","journal-title":"Curr Neuropharmacol"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"mfab035","DOI":"10.1093\/mtomcs\/mfab035","volume":"13","author":"Ma M.","year":"2021","unstructured":"Ma M.; Qiu B.; Jin J.; Wang J.; Nie Y.; Liang Y.; Yu Z.; Teng C.B.; Establishment of a specific in vivo Cu(\u2160) reporting system based on metallothionein screening. Metallomics 2021,13(7),mfab035","journal-title":"Metallomics"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"105264","DOI":"10.1016\/j.phrs.2020.105264","volume":"171","author":"Memariani Z.","year":"2021","unstructured":"Memariani Z.; Abbas S.Q.; ul Hassan, S.S.; Ahmadi, A.; Chabra, A. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review. Pharmacol Res 2021,171,105264","journal-title":"Pharmacol Res"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fphar.2020.00933","volume":"11","author":"Yuan J.","year":"2020","unstructured":"Yuan J.; Wei F.; Luo X.; Zhang M.; Qiao R.; Zhong M.; Chen H.; Yang W.; Multi-component comparative pharmacokinetics in rats after oral administration of Fructus aurantii extract, naringin, neohesperidin, and naringin-neohesperidin. Front Pharmacol 2020,11,933","journal-title":"Front Pharmacol"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/283941","volume":"2013","author":"Chen K.Y.","year":"2013","unstructured":"Chen K.Y.; Lin K.C.; Chen Y.S.; Yao C.H.; A novel porous gelatin composite containing naringin for bone repair. Evid Based Complement Alternat Med 2013,2013,1-10","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1248\/bpb.b20-00574","volume":"44","author":"Guo L.X.","year":"2021","unstructured":"Guo L.X.; Sun, B. N\u2032-1,10-Bis(Naringin) Triethylenetetraamine, synthesis and as a Cu(II) chelator for Alzheimer\u2019s disease therapy. Biol Pharm Bull 2021,44(1),51-56","journal-title":"Biol Pharm Bull"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1080\/07391102.2018.1511475","volume":"37","author":"Saini R.K.","year":"2019","unstructured":"Saini R.K.; Shuaib S.; Goyal D.; Goyal B.; Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against A&#x3B2;42 aggregation and protofibril destabilization: A molecular dynamics simulation study. J Biomol Struct Dyn 2019,37(12),3183-3197","journal-title":"J Biomol Struct Dyn"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.1039\/C4OB00998C","volume":"12","author":"Mao F.","year":"2014","unstructured":"Mao F.; Yan J.; Li J.; Jia X.; Miao H.; Sun Y.; Huang L.; Li X.; New multi-target-directed small molecules against Alzheimer\u2019s disease: a combination of resveratrol and clioquinol. Org Biomol Chem 2014,12(31),5936-5944","journal-title":"Org Biomol Chem"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666231103085859","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/223092\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X22666231103085859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:14:45Z","timestamp":1730740485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/223092\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":215,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x22666231103085859","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}